Novogen up 19.5% in the states

Novogen shares rose to $4.60 over night hitting a day high of $4.70.

At the closing price of $4.60 this equates to $1.67 in our terms. The volume was 3.75 times higher than the average daily trading volume.

I think we'll see investors (including brokerage houses) slowly recognise the significance of recent deals + positive developments. The recent news includes the HRT scare that should boost Promensil sales along with positive testing news of the anti-cancer drug Phenoxodiol. New clinical trials at Yale university and NIDCR shows just how much recognition the medical community is giving Novogen.

It sounds silly but I believe NRT should be trading at levels over double current levels. Hopefully NRT release commentary regarding recent trials so negate fears about delays in Phenoxodiol testing.